Transarterial radioembolization (TARE) with yttrium 90 has increasingly been performed to
treat hepatocellular carcinoma (HCC). TARE was historically used as a palliative lobar …

With the rising incidence of hepatocellular carcinoma, there has been increasing use of local-
regional therapy (LRT) to downstage or bridge to transplant, for definitive treatment, and for …

Conventional transarterial chemoembolization (cTACE) utilizing ethiodized oil as a
chemotherapy carrier has become a standard treatment for intermediate-stage …

Liver cirrhosis is the diffuse and advanced phase of liver disease. Several morphological
methods are used for imaging modalities. But, these modalities are biased and lack in …

Background: Liver Imaging Reporting and Data Systems (LI-RADS) Treatment Response
Algorithm (TRA) was created to provide a standardized assessment of hepatocellular …

Purpose Our purpose was to evaluate the accuracy of LI-RADS Treatment Response
Algorithm (LR-TRA) for assessing the viability of hepatocellular carcinoma (HCC) treated …

As the incidence of hepatocellular carcinoma (HCC) and subsequent treatments with liver‐
directed therapies rise, the complexity of assessing lesion response has also increased. The …

Purpose To summarize the magnetic resonance imaging manifestations of hepatocellular
carcinoma (HCC) with and without progression after stereotactic body radiation therapy …

The liver is supplied by a dual blood flow system consisting of the portal vein and hepatic
artery. Imaging techniques for diagnosing hepatocellular carcinoma (HCC) have been …

HCC incidence continues to increase worldwide and is most frequently discovered at an
advanced stage when limited curative options are available. Combination locoregional …